HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,306,165 | -48.6% | 314,500 | -44.9% | 3.47% | -43.2% |
| Q2 2023 | $20,070,190 | +7.8% | 570,500 | 0.0% | 6.11% | +17.6% |
| Q1 2023 | $18,621,120 | +27.9% | 570,500 | +115.7% | 5.20% | +15.5% |
| Q4 2022 | $14,560,725 | +24.3% | 264,500 | 0.0% | 4.50% | +19.7% |
| Q3 2022 | $11,715,000 | -94.7% | 264,500 | +2350.4% | 3.76% | +62.6% |
| Q2 2022 | $221,500,000 | +978.8% | 10,794 | -94.7% | 2.31% | -50.1% |
| Q1 2022 | $20,533,000 | +104.0% | 205,474 | -12.9% | 4.63% | +106.6% |
| Q4 2021 | $10,063,000 | +11.6% | 236,000 | 0.0% | 2.24% | +3.0% |
| Q3 2021 | $9,020,000 | +92.5% | 236,000 | +42.2% | 2.18% | +75.9% |
| Q2 2021 | $4,686,000 | – | 166,000 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |